> 0 1 0 1 O
18 1 3 1 3 B-lower_bound
years 4 9 4 9 I-lower_bound
of 10 12 10 12 O
age 13 16 13 16 B-age

Clinically 0 10 17 27 O
significant 11 22 28 39 O
elevation 23 32 40 49 O
of 33 35 50 52 O
GGT 36 39 53 56 B-clinical_variable
( 40 41 57 58 O
> 41 42 58 59 O
1.5xULN 42 49 59 66 B-lower_bound
) 49 50 66 67 O
, 50 51 67 68 O
bilirubin 52 61 69 78 B-clinical_variable
( 62 63 79 80 O
> 63 64 80 81 O
1.25xULN 64 72 81 89 B-lower_bound
, 72 73 89 90 O
direct 74 80 91 97 O
35 81 83 98 100 O
% 83 84 100 101 O
) 84 85 101 102 O
, 85 86 102 103 O
or 87 89 104 106 O
INR 90 93 107 110 B-clinical_variable
( 94 95 111 112 O
> 95 96 112 113 O
1.2 96 99 113 116 O
, 99 100 116 117 O
excluding 101 110 118 127 O
patients 111 119 128 136 O
on 120 122 137 139 O
anti 123 127 140 144 B-treatment
- 127 128 144 145 I-treatment
coagulant 128 137 145 154 I-treatment
therapies 138 147 155 164 I-treatment
) 147 148 164 165 O
or 149 151 166 168 O
other 152 157 169 174 O
clinically 158 168 175 185 O
significant 169 180 186 197 O
abnormal 181 189 198 206 O
laboratory 190 200 207 217 O
value 201 206 218 223 O
in 207 209 224 226 O
the 210 213 227 230 O
opinion 214 221 231 238 O
of 222 224 239 241 O
the 225 228 242 245 O
investigator 229 241 246 258 O

Complete 0 8 259 267 O
abstinence 9 19 268 278 O
from 20 24 279 283 O
intercourse 25 36 284 295 O
from 37 41 296 300 O
2 42 43 301 302 B-upper_bound
weeks 44 49 303 308 I-upper_bound
prior 50 55 309 314 I-upper_bound
to 56 58 315 317 O
administration 59 73 318 332 O
of 74 76 333 335 O
the 77 80 336 339 O
1st 81 84 340 343 O
dose 85 89 344 348 O
of 90 92 349 351 O
study 93 98 352 357 O
agent 99 104 358 363 O
until 105 110 364 369 O
16 111 113 370 372 B-upper_bound
weeks 114 119 373 378 I-upper_bound
after 120 125 379 384 O
the 126 129 385 388 O
last 130 134 389 393 O
dose 135 139 394 398 O
of 140 142 399 401 O
study 143 148 402 407 O
agent 149 154 408 413 O
( 155 156 414 415 O
Sexual 156 162 415 421 O
inactivity 163 173 422 432 O
by 174 176 433 435 O
abstinence 177 187 436 446 O
must 188 192 447 451 O
be 193 195 452 454 O
consistent 196 206 455 465 O
with 207 211 466 470 O
the 212 215 471 474 O
preferred 216 225 475 484 O
and 226 229 485 488 O
usual 230 235 489 494 O
lifestyle 236 245 495 504 O
of 246 248 505 507 O
the 249 252 508 511 O
subject 253 260 512 519 O
. 260 261 519 520 O
Periodic 262 270 521 529 O
abstinence 271 281 530 540 O
( 282 283 541 542 O
e.g. 283 287 542 546 O
calendar 288 296 547 555 O
, 296 297 555 556 O
ovulation 298 307 557 566 O
, 307 308 566 567 O
symptothermal 309 322 568 581 O
, 322 323 581 582 O
post 324 328 583 587 O
- 328 329 587 588 O
ovulation 329 338 588 597 O
methods 339 346 598 605 O
) 346 347 605 606 O
and 348 351 607 610 O
withdrawal 352 362 611 621 O
are 363 366 622 625 O
not 367 370 626 629 O
acceptable 371 381 630 640 O
methods 382 389 641 648 O
of 390 392 649 651 O
contraception 393 406 652 665 O
) 406 407 665 666 O

Consistent 0 10 667 677 O
and 11 14 678 681 O
correct 15 22 682 689 O
use 23 26 690 693 B-contraception_consent
of 27 29 694 696 I-contraception_consent
2 30 31 697 698 I-contraception_consent
of 32 34 699 701 I-contraception_consent
acceptable 35 45 702 712 I-contraception_consent
methods 46 53 713 720 I-contraception_consent
of 54 56 721 723 I-contraception_consent
birth 57 62 724 729 I-contraception_consent
control 63 70 730 737 I-contraception_consent
for 71 74 738 741 O
1 75 76 742 743 B-upper_bound
month 77 82 744 749 I-upper_bound
prior 83 88 750 755 I-upper_bound
to 89 91 756 758 O
the 92 95 759 762 O
start 96 101 763 768 O
of 102 104 769 771 O
the 105 108 772 775 O
study 109 114 776 781 O
agent 115 120 782 787 O
, 120 121 787 788 O
during 122 128 789 795 O
the 129 132 796 799 O
study 133 138 800 805 O
, 138 139 805 806 O
and 140 143 807 810 O
16 144 146 811 813 B-upper_bound
weeks 147 152 814 819 I-upper_bound
after 153 158 820 825 O
the 159 162 826 829 O
last 163 167 830 834 O
dose 168 172 835 839 O
of 173 175 840 842 O
study 176 181 843 848 O
agent 182 187 849 854 O

Currently 0 9 855 864 O
on 10 12 865 867 O
any 13 16 868 871 O
suppressive 17 28 872 883 B-treatment
therapy 29 36 884 891 I-treatment
for 37 40 892 895 O
a 41 42 896 897 O
chronic 43 50 898 905 B-chronic_disease
infection 51 60 906 915 I-chronic_disease
( 61 62 916 917 O
such 62 66 917 921 O
as 67 69 922 924 O
tuberculosis 70 82 925 937 B-chronic_disease
- 83 84 938 939 O
including 85 94 940 949 O
latent 95 101 950 956 B-chronic_disease
tuberculosis 102 114 957 969 I-chronic_disease
, 114 115 969 970 O
pneumocystis 116 128 971 983 B-chronic_disease
, 128 129 983 984 O
cytomegalovirus 130 145 985 1000 B-chronic_disease
, 145 146 1000 1001 O
herpes 147 153 1002 1008 B-chronic_disease
simplex 154 161 1009 1016 I-chronic_disease
virus 162 167 1017 1022 I-chronic_disease
, 167 168 1022 1023 O
herpes 169 175 1024 1030 B-chronic_disease
zoster 176 182 1031 1037 I-chronic_disease
and 183 186 1038 1041 O
atypical 187 195 1042 1050 B-chronic_disease
mycobacteria 196 208 1051 1063 I-chronic_disease
) 208 209 1063 1064 O

Definite 0 8 1065 1073 O
or 9 11 1074 1076 O
probable 12 20 1077 1085 O
diagnosis 21 30 1086 1095 O
of 31 33 1096 1098 O
polymyositis 34 46 1099 1111 B-chronic_disease
( 47 48 1112 1113 I-chronic_disease
PM 48 50 1113 1115 I-chronic_disease
) 50 51 1115 1116 I-chronic_disease
with 52 56 1117 1121 O
presence 57 65 1122 1130 O
of 66 68 1131 1133 O
one 69 72 1134 1137 O
of 73 75 1138 1140 O
myositis 76 84 1141 1149 O
specific 85 93 1150 1158 O
antibodies 94 104 1159 1169 O

Dermatomyositis 0 15 1170 1185 B-chronic_disease
patients 16 24 1186 1194 O
that 25 29 1195 1199 O
do 30 32 1200 1202 O
not 33 36 1203 1206 O
meet 37 41 1207 1211 O
the 42 45 1212 1215 O
MMT 46 49 1216 1219 O
criteria 50 58 1220 1228 O

Discontinuation 0 15 1229 1244 O
IS 16 18 1245 1247 B-treatment
agent 19 24 1248 1253 I-treatment
< 25 26 1254 1255 O
3 27 28 1256 1257 B-upper_bound
months 29 35 1258 1264 I-upper_bound
prior 36 41 1265 1270 I-upper_bound
to 42 44 1271 1273 O
Screening 45 54 1274 1283 O

Female 0 6 1284 1290 B-gender
subjects 7 15 1291 1299 I-gender
of 16 18 1300 1302 O
childbearing 19 31 1303 1315 O
potential 32 41 1316 1325 O
must 42 46 1326 1330 O
have 47 51 1331 1335 O
a 52 53 1336 1337 O
negative 54 62 1338 1346 B-pregnancy
urine 63 68 1347 1352 I-pregnancy
pregnancy 69 78 1353 1362 I-pregnancy
test 79 83 1363 1367 O
at 84 86 1368 1370 O
screening 87 96 1371 1380 O

Have 0 4 1381 1385 O
a 5 6 1386 1387 O
historically 7 19 1388 1400 O
positive 20 28 1401 1409 O
HIV 29 32 1410 1413 B-chronic_disease
test 33 37 1414 1418 O
or 38 40 1419 1421 O
test 41 45 1422 1426 O
positive 46 54 1427 1435 O
at 55 57 1436 1438 O
screening 58 67 1439 1448 O
for 68 71 1449 1452 O
HIV 72 75 1453 1456 O

Have 0 4 1457 1461 O
a 5 6 1462 1463 O
history 7 14 1464 1471 O
of 15 17 1472 1474 O
a 18 19 1475 1476 O
primary 20 27 1477 1484 B-chronic_disease
immunodeficiency 28 44 1485 1501 I-chronic_disease

Have 0 4 1502 1506 O
a 5 6 1507 1508 O
history 7 14 1509 1516 O
of 15 17 1517 1519 O
an 18 20 1520 1522 O
anaphylactic 21 33 1523 1535 O
reaction 34 42 1536 1544 O
to 43 45 1545 1547 O
parenteral 46 56 1548 1558 O
administration 57 71 1559 1573 O
of 72 74 1574 1576 O
contrast 75 83 1577 1585 B-allergy_name
agents 84 90 1586 1592 I-allergy_name
, 90 91 1592 1593 O
human 92 97 1594 1599 O
or 98 100 1600 1602 I-allergy_name
murine 101 107 1603 1609 I-allergy_name
proteins 108 116 1610 1618 I-allergy_name
or 117 119 1619 1621 I-allergy_name
monoclonal 120 130 1622 1632 I-allergy_name
antibodies 131 141 1633 1643 I-allergy_name

Have 0 4 1644 1648 O
a 5 6 1649 1650 O
history 7 14 1651 1658 O
of 15 17 1659 1661 O
autoimmune 18 28 1662 1672 B-chronic_disease
hepatitis 29 38 1673 1682 I-chronic_disease

Have 0 4 1683 1687 O
a 5 6 1688 1689 O
significant 7 18 1690 1701 O
IgG 19 22 1702 1705 B-chronic_disease
deficiency 23 33 1706 1716 I-chronic_disease
( 34 35 1717 1718 O
IgG 35 38 1718 1721 B-clinical_variable
level 39 44 1722 1727 I-clinical_variable
< 45 46 1728 1729 O
400 47 50 1730 1733 B-upper_bound
mg 51 53 1734 1736 I-upper_bound
/ 53 54 1736 1737 I-upper_bound
dl 54 56 1737 1739 I-upper_bound
) 56 57 1739 1740 O
Have 58 62 1741 1745 O
an 63 65 1746 1748 O
IgA 66 69 1749 1752 B-chronic_disease
deficiency 70 80 1753 1763 I-chronic_disease
( 81 82 1764 1765 O
IgA 82 85 1765 1768 B-clinical_variable
level 86 91 1769 1774 I-clinical_variable
< 92 93 1775 1776 O
10 94 96 1777 1779 B-upper_bound
mg 97 99 1780 1782 I-upper_bound
/ 99 100 1782 1783 I-upper_bound
dL 100 102 1783 1785 I-upper_bound
) 102 103 1785 1786 O

Have 0 4 1787 1791 O
a 5 6 1792 1793 O
stable 7 13 1794 1800 O
background 14 24 1801 1811 O
glucocorticoid 25 39 1812 1826 B-treatment
therapy 40 47 1827 1834 I-treatment
for 48 51 1835 1838 O
at 52 54 1839 1841 O
least 55 60 1842 1847 O
2 61 62 1848 1849 B-lower_bound
weeks 63 68 1850 1855 I-lower_bound
prior 69 74 1856 1861 I-lower_bound
to 75 77 1862 1864 O
screening 78 87 1865 1874 O
( 88 89 1875 1876 O
Prednisone 89 99 1876 1886 B-treatment
( 100 101 1887 1888 O
or 101 103 1888 1890 O
equivalent 104 114 1891 1901 O
) 114 115 1901 1902 O
dose 116 120 1903 1907 B-clinical_variable
< 121 122 1908 1909 O
15 123 125 1910 1912 B-upper_bound
mg 126 128 1913 1915 I-upper_bound
daily 129 134 1916 1921 I-upper_bound
) 134 135 1921 1922 O

Have 0 4 1923 1927 O
a 5 6 1928 1929 O
stable 7 13 1930 1936 O
immunosuppressive 14 31 1937 1954 B-treatment
therapy 32 39 1955 1962 I-treatment
( 40 41 1963 1964 O
IS 41 43 1964 1966 O
) 43 44 1966 1967 O
( 45 46 1968 1969 O
azathioprine 46 58 1969 1981 B-treatment
, 58 59 1981 1982 O
mycophenolate 60 73 1983 1996 B-treatment
mofetil 74 81 1997 2004 B-treatment
, 81 82 2004 2005 O
tacrolimus 83 93 2006 2016 B-treatment
, 93 94 2016 2017 O
cyclosporine 95 107 2018 2030 B-treatment
for 108 111 2031 2034 O
> 112 113 2035 2036 O
2 114 115 2037 2038 B-lower_bound
months 116 122 2039 2045 I-lower_bound
prior 123 128 2046 2051 I-lower_bound
to 129 131 2052 2054 O
screening 132 141 2055 2064 O

Have 0 4 2065 2069 O
any 5 8 2070 2073 O
concurrent 9 19 2074 2084 O
significant 20 31 2085 2096 O
medical 32 39 2097 2104 O
or 40 42 2105 2107 O
psychiatric 43 54 2108 2119 B-chronic_disease
illness 55 62 2120 2127 I-chronic_disease
that 63 67 2128 2132 O
the 68 71 2133 2136 O
investigator 72 84 2137 2149 O
considers 85 94 2150 2159 O
would 95 100 2160 2165 O
make 101 105 2166 2170 O
the 106 109 2171 2174 O
candidate 110 119 2175 2184 O
unsuitable 120 130 2185 2195 O
for 131 134 2196 2199 O
the 135 138 2200 2203 O
study 139 144 2204 2209 O

Have 0 4 2210 2214 O
current 5 12 2215 2222 O
drug 13 17 2223 2227 O
or 18 20 2228 2230 O
alcohol 21 28 2231 2238 O
abuse 29 34 2239 2244 O
or 35 37 2245 2247 O
dependence 38 48 2248 2258 O
, 48 49 2258 2259 O
or 50 52 2260 2262 O
a 53 54 2263 2264 O
history 55 62 2265 2272 O
of 63 65 2273 2275 O
drug 66 70 2276 2280 O
or 71 73 2281 2283 O
alcohol 74 81 2284 2291 O
abuse 82 87 2292 2297 O
or 88 90 2298 2300 O
dependence 91 101 2301 2311 O
within 102 108 2312 2318 O
364 109 112 2319 2322 B-upper_bound
days 113 117 2323 2327 I-upper_bound
prior 118 123 2328 2333 I-upper_bound
to 124 126 2334 2336 O
Day 127 130 2337 2340 O
0 131 132 2341 2342 O

Have 0 4 2343 2347 O
received 5 13 2348 2356 O
a 14 15 2357 2358 O
biologic 16 24 2359 2367 B-treatment
investigational 25 40 2368 2383 I-treatment
agent 41 46 2384 2389 I-treatment
within 47 53 2390 2396 O
365 54 57 2397 2400 B-upper_bound
days 58 62 2401 2405 I-upper_bound
prior 63 68 2406 2411 I-upper_bound
to 69 71 2412 2414 O
Screening 72 81 2415 2424 O

Have 0 4 2425 2429 O
received 5 13 2430 2438 O
a 14 15 2439 2440 O
non 16 19 2441 2444 B-treatment
- 19 20 2444 2445 I-treatment
biologic 20 28 2445 2453 I-treatment
investigational 29 44 2454 2469 I-treatment
agent 45 50 2470 2475 I-treatment
within 51 57 2476 2482 O
30 58 60 2483 2485 B-upper_bound
days 61 65 2486 2490 I-upper_bound
or 66 68 2491 2493 O
5 69 70 2494 2495 B-upper_bound
half 71 75 2496 2500 I-upper_bound
- 75 76 2500 2501 I-upper_bound
lives 76 81 2501 2506 I-upper_bound
of 82 84 2507 2509 O
the 85 88 2510 2513 O
agent 89 94 2514 2519 O
( 95 96 2520 2521 O
whichever 96 105 2521 2530 O
is 106 108 2531 2533 O
longer 109 115 2534 2540 O
) 115 116 2540 2541 O
prior 117 122 2542 2547 O
to 123 125 2548 2550 O
Screening 126 135 2551 2560 O

Have 0 4 2561 2565 O
received 5 13 2566 2574 O
cyclophosphamide 14 30 2575 2591 B-treatment
within 31 37 2592 2598 O
180 38 41 2599 2602 B-upper_bound
days 42 46 2603 2607 I-upper_bound
prior 47 52 2608 2613 I-upper_bound
to 53 55 2614 2616 O
Screening 56 65 2617 2626 O

Have 0 4 2627 2631 O
received 5 13 2632 2640 O
treatment 14 23 2641 2650 B-treatment
with 24 28 2651 2655 I-treatment
Belimumab 29 38 2656 2665 I-treatment
at 39 41 2666 2668 O
any 42 45 2669 2672 O
time 46 50 2673 2677 O
prior 51 56 2678 2683 O
to 57 59 2684 2686 O
Screening 60 69 2687 2696 O

Have 0 4 2697 2701 O
refractory 5 15 2702 2712 O
IIM 16 19 2713 2716 B-chronic_disease
as 20 22 2717 2719 O
defined 23 30 2720 2727 O
by 31 33 2728 2730 O
inadequate 34 44 2731 2741 O
response 45 53 2742 2750 O
or 54 56 2751 2753 O
intolerance 57 68 2754 2765 O
to 69 71 2766 2768 O
at 72 74 2769 2771 O
least 75 80 2772 2777 O
3 81 82 2778 2779 B-lower_bound
months 83 89 2780 2786 I-lower_bound
of 90 92 2787 2789 O
glucocorticoids 93 108 2790 2805 B-allergy_name

Have 0 4 2806 2810 O
severe 5 11 2811 2817 O
muscle 12 18 2818 2824 O
damage 19 25 2825 2831 O
as 26 28 2832 2834 O
defined 29 36 2835 2842 O
by 37 39 2843 2845 O
a 40 41 2846 2847 O
Muscle 42 48 2848 2854 B-clinical_variable
Damage 49 55 2855 2861 I-clinical_variable
Index 56 61 2862 2867 I-clinical_variable
( 62 63 2868 2869 I-clinical_variable
MDI 63 66 2869 2872 I-clinical_variable
) 66 67 2872 2873 I-clinical_variable
> 68 69 2874 2875 O
5.0 70 73 2876 2879 B-lower_bound
cm 74 76 2880 2882 I-lower_bound
using 77 82 2883 2888 O
a 83 84 2889 2890 O
visual 85 91 2891 2897 B-clinical_variable
analogue 92 100 2898 2906 I-clinical_variable
scale 101 106 2907 2912 I-clinical_variable
( 107 108 2913 2914 I-clinical_variable
VAS 108 111 2914 2917 I-clinical_variable
) 111 112 2917 2918 I-clinical_variable
10.0 113 117 2919 2923 O
cm 118 120 2924 2926 O
in 121 123 2927 2929 O
length 124 130 2930 2936 O
or 131 133 2937 2939 O
evidence 134 142 2940 2948 O
of 143 145 2949 2951 O
severe 146 152 2952 2958 O
muscle 153 159 2959 2965 B-chronic_disease
atrophy 160 167 2966 2973 I-chronic_disease
on 168 170 2974 2976 O
muscle 171 177 2977 2983 B-treatment
MRI 178 181 2984 2987 I-treatment

Hepatitis 0 9 2988 2997 B-chronic_disease
status 10 16 2998 3004 O
will 17 21 3005 3009 O
be 22 24 3010 3012 O
obtained 25 33 3013 3021 O
from 34 38 3022 3026 O
patients 39 47 3027 3035 O
' 47 48 3035 3036 O
medical 49 56 3037 3044 O
records 57 64 3045 3052 O

History 0 7 3053 3060 O
of 8 10 3061 3063 O
malignant 11 20 3064 3073 B-cancer
neoplasm 21 29 3074 3082 I-cancer
within 30 36 3083 3089 O
the 37 40 3090 3093 O
last 41 45 3094 3098 B-upper_bound
5 46 47 3099 3100 I-upper_bound
years 48 53 3101 3106 I-upper_bound
, 53 54 3106 3107 O
except 55 61 3108 3114 O
for 62 65 3115 3118 O
adequately 66 76 3119 3129 O
treated 77 84 3130 3137 O
cancers 85 92 3138 3145 B-cancer
of 93 95 3146 3148 I-cancer
the 96 99 3149 3152 I-cancer
skin 100 104 3153 3157 I-cancer
( 105 106 3158 3159 O
basal 106 111 3159 3164 B-cancer
or 112 114 3165 3167 O
squamous 115 123 3168 3176 B-cancer
cell 124 128 3177 3181 I-cancer
) 128 129 3181 3182 O

Hospitalization 0 15 3183 3198 O
for 16 19 3199 3202 O
treatment 20 29 3203 3212 B-treatment
of 30 32 3213 3215 O
infection 33 42 3216 3225 B-chronic_disease
within 43 49 3226 3232 O
60 50 52 3233 3235 B-upper_bound
days 53 57 3236 3240 I-upper_bound
of 58 60 3241 3243 O
Day 61 64 3244 3247 O
0 65 66 3248 3249 O

Initiated 0 9 3250 3259 O
IVIG 10 14 3260 3264 B-clinical_variable
3 15 16 3265 3266 B-upper_bound
months 17 23 3267 3273 I-upper_bound
prior 24 29 3274 3279 I-upper_bound
to 30 32 3280 3282 O
Screening 33 42 3283 3292 O

Patients 0 8 3293 3301 O
on 9 11 3302 3304 O
intravenous 12 23 3305 3316 B-treatment
gamma 24 29 3317 3322 I-treatment
globulin 30 38 3323 3331 I-treatment
( 39 40 3332 3333 I-treatment
IVIG 40 44 3333 3337 I-treatment
) 44 45 3337 3338 I-treatment
have 46 50 3339 3343 O
to 51 53 3344 3346 O
be 54 56 3347 3349 O
on 57 59 3350 3352 O
a 60 61 3353 3354 O
stable 62 68 3355 3361 O
dose 69 73 3362 3366 O
and 74 77 3367 3370 O
frequency 78 87 3371 3380 B-clinical_variable
regimen 88 95 3381 3388 I-clinical_variable
for 96 99 3389 3392 O
≥ 100 101 3393 3394 O
3 102 103 3395 3396 B-lower_bound
months 104 110 3397 3403 I-lower_bound

Presence 0 8 3404 3412 O
of 9 11 3413 3415 O
positive 12 20 3416 3424 O
autoantibody 21 33 3425 3437 B-clinical_variable
( 34 35 3438 3439 O
ANA 35 38 3439 3442 B-clinical_variable
> 39 40 3443 3444 O
1:80 40 44 3444 3448 B-lower_bound
or 45 47 3449 3451 O
RNP 48 51 3452 3455 B-clinical_variable
or 52 54 3456 3458 O
SSA 55 58 3459 3462 B-clinical_variable
/ 58 59 3462 3463 O
SSB 59 62 3463 3466 B-clinical_variable
or 63 65 3467 3469 O
any 66 69 3470 3473 O
of 70 72 3474 3476 O
the 73 76 3477 3480 O
myositis 77 85 3481 3489 B-chronic_disease
specific 86 94 3490 3498 O
autoantibody 95 107 3499 3511 O
: 107 108 3511 3512 O
antisynthetase 109 123 3513 3527 B-clinical_variable
autoantibodies 124 138 3528 3542 I-clinical_variable
( 139 140 3543 3544 O
anti 140 144 3544 3548 B-clinical_variable
- 144 145 3548 3549 I-clinical_variable
Jo-1 145 149 3549 3553 I-clinical_variable
, 149 150 3553 3554 O
PL-7 151 155 3555 3559 B-clinical_variable
, 155 156 3559 3560 O
PL-12 157 162 3561 3566 B-clinical_variable
, 162 163 3566 3567 O
EJ 164 166 3568 3570 B-clinical_variable
, 166 167 3570 3571 O
OJ 168 170 3572 3574 B-clinical_variable
, 170 171 3574 3575 O
KS 172 174 3576 3578 B-clinical_variable
) 174 175 3578 3579 O
, 175 176 3579 3580 O
anti 177 181 3581 3585 B-clinical_variable
- 181 182 3585 3586 I-clinical_variable
SRP 182 185 3586 3589 I-clinical_variable
, 185 186 3589 3590 O
anti 187 191 3591 3595 B-clinical_variable
- 191 192 3595 3596 I-clinical_variable
Mi-2 192 196 3596 3600 I-clinical_variable
, 196 197 3600 3601 O
anti 198 202 3602 3606 B-clinical_variable
- 202 203 3606 3607 I-clinical_variable
p140 203 207 3607 3611 I-clinical_variable
) 207 208 3611 3612 O

Pulse 0 5 3613 3618 B-treatment
steroids 6 14 3619 3627 I-treatment
2 15 16 3628 3629 B-upper_bound
months 17 23 3630 3636 I-upper_bound
prior 24 29 3637 3642 I-upper_bound
to 30 32 3643 3645 O
Screening 33 42 3646 3655 O

Use 0 3 3656 3659 O
of 4 6 3660 3662 O
parenteral 7 17 3663 3673 B-treatment
( 18 19 3674 3675 I-treatment
IV 19 21 3675 3677 I-treatment
or 22 24 3678 3680 I-treatment
IM 25 27 3681 3683 I-treatment
) 27 28 3683 3684 I-treatment
antibiotics 29 40 3685 3696 I-treatment
( 41 42 3697 3698 O
antibacterials 42 56 3698 3712 B-treatment
, 56 57 3712 3713 O
antivirals 58 68 3714 3724 B-treatment
, 68 69 3724 3725 O
anti 70 74 3726 3730 B-treatment
- 74 75 3730 3731 I-treatment
fungals 75 82 3731 3738 I-treatment
, 82 83 3738 3739 O
or 84 86 3740 3742 O
anti 87 91 3743 3747 B-treatment
parasitic 92 101 3748 3757 I-treatment
agents 102 108 3758 3764 I-treatment
) 108 109 3764 3765 O
within 110 116 3766 3772 O
60 117 119 3773 3775 B-upper_bound
days 120 124 3776 3780 I-upper_bound
of 125 127 3781 3783 O
Day 128 131 3784 3787 O

a 0 1 3788 3789 O
cutaneous 2 11 3790 3799 O
VAS 12 15 3800 3803 B-clinical_variable
score 16 21 3804 3809 I-clinical_variable
of 22 24 3810 3812 O
> 25 26 3813 3814 O
3 26 27 3814 3815 B-lower_bound
cm 28 30 3816 3818 I-lower_bound
on 31 33 3819 3821 O
a 34 35 3822 3823 O
10 36 38 3824 3826 O
cm 39 41 3827 3829 O
VAS 42 45 3830 3833 O
scale 46 51 3834 3839 O
( 52 53 3840 3841 O
MDAAT 53 58 3841 3846 O
) 58 59 3846 3847 O
will 60 64 3848 3852 O
be 65 67 3853 3855 O
required 68 76 3856 3864 O

any 0 3 3865 3868 O
suicidal 4 12 3869 3877 O
ideation 13 21 3878 3886 O
in 22 24 3887 3889 O
the 25 28 3890 3893 O
last 29 33 3894 3898 O
2 34 35 3899 3900 B-upper_bound
months 36 42 3901 3907 I-upper_bound
or 43 45 3908 3910 O
who 46 49 3911 3914 O
in 50 52 3915 3917 O
the 53 56 3918 3921 O
investigator 57 69 3922 3934 O
's 69 71 3934 3936 O
judgment 72 80 3937 3945 O
, 80 81 3945 3946 O
pose 82 86 3947 3951 O
a 87 88 3952 3953 O
significant 89 100 3954 3965 O
suicide 101 108 3966 3973 O
risk 109 113 3974 3978 O

ave 0 3 3979 3982 O
evidence 4 12 3983 3991 O
of 13 15 3992 3994 O
serious 16 23 3995 4002 O
suicide 24 31 4003 4010 B-chronic_disease
risk 32 36 4011 4015 O
including 37 46 4016 4025 O
any 47 50 4026 4029 O
history 51 58 4030 4037 O
of 59 61 4038 4040 O
suicidal 62 70 4041 4049 B-chronic_disease
behaviour 71 80 4050 4059 O
in 81 83 4060 4062 O
the 84 87 4063 4066 O
last 88 92 4067 4071 O
6 93 94 4072 4073 B-upper_bound
months 95 101 4074 4080 I-upper_bound

azathioprine 0 12 4081 4093 B-treatment
, 12 13 4093 4094 O
methotrexate 14 26 4095 4107 B-treatment
, 26 27 4107 4108 O
mycophenolate 28 41 4109 4122 B-treatment
mofetil 42 49 4123 4130 I-treatment
, 49 50 4130 4131 O
leflunomide 51 62 4132 4143 B-treatment
, 62 63 4143 4144 O
tacrolimus 64 74 4145 4155 B-treatment
, 74 75 4155 4156 O
cyclosporine 76 88 4157 4169 B-treatment
, 88 89 4169 4170 O
or 90 92 4171 4173 O
intravenous 93 104 4174 4185 B-treatment
gamma 105 110 4186 4191 I-treatment
globulin 111 119 4192 4200 I-treatment
[ 120 121 4201 4202 I-treatment
IVIG 121 125 4202 4206 I-treatment
] 125 126 4206 4207 I-treatment

definite 0 8 4208 4216 O
or 9 11 4217 4219 O
probable 12 20 4220 4228 O
dermatomyositis 21 36 4229 4244 B-chronic_disease
( 37 38 4245 4246 I-chronic_disease
DM 38 40 4246 4248 I-chronic_disease
) 40 41 4248 4249 I-chronic_disease

patients 0 8 4250 4258 O
with 9 13 4259 4263 O
≥ 14 15 4264 4265 O
7 16 17 4266 4267 B-lower_bound
years 18 23 4268 4273 I-lower_bound
of 24 26 4274 4276 O
IIM 27 30 4277 4280 B-chronic_disease
, 30 31 4280 4281 O
muscle 32 38 4282 4288 B-treatment
biopsy 39 45 4289 4295 I-treatment
or 46 48 4296 4298 O
muscle 49 55 4299 4305 B-treatment
MRI 56 59 4306 4309 I-treatment
within 60 66 4310 4316 O
4 67 68 4317 4318 B-upper_bound
months 69 75 4319 4325 I-upper_bound
prior 76 81 4326 4331 I-upper_bound
to 82 84 4332 4334 O
enrollment 85 95 4335 4345 O
will 96 100 4346 4350 O
be 101 103 4351 4353 O
required 104 112 4354 4362 O
to 113 115 4363 4365 O
document 116 124 4366 4374 O
active 125 131 4375 4381 O
myositis 132 140 4382 4390 B-chronic_disease
to 141 143 4391 4393 O
avoid 144 149 4394 4399 O
enrolling 150 159 4400 4409 O
patients 160 168 4410 4418 O
with 169 173 4419 4423 O
significant 174 185 4424 4435 O
index 186 191 4436 4441 O
of 192 194 4442 4444 O
damage/ 195 202 4445 4452 O
muscle 203 209 4453 4459 O
atrophy 210 217 4460 4467 O

requires 0 8 4468 4476 O
at 9 11 4477 4479 O
least 12 17 4480 4485 O
3 18 19 4486 4487 B-lower_bound
criteria 20 28 4488 4496 O
from 29 33 4497 4501 O
the 34 37 4502 4505 O
CSM 38 41 4506 4509 B-clinical_variable

